Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica
NCT04799262
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Polymyalgia Rheumatica
Effect of Drug
Safety Issues
Interventions
DRUG:
Tofacitinib 5 MG
Sponsor
RenJi Hospital